Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
Schneider G, Geppert T, Hartenfeller M, Reisen F, Klenner A, Reutlinger M, Hähnke V, Hiss JA, Zettl H, Keppner S, Spänkuch B, Schneider P.
Schneider G, et al. Among authors: geppert t.
Future Med Chem. 2011 Mar;3(4):415-24. doi: 10.4155/fmc.11.8.
Future Med Chem. 2011.
PMID: 21452978